Wave Life Sciences Ltd. - Ordinary Shares (WVE): Price and Financial Metrics


Wave Life Sciences Ltd. - Ordinary Shares (WVE): $2.18

-0.21 (-8.79%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

WVE POWR Grades


  • WVE scores best on the Sentiment dimension, with a Sentiment rank ahead of 88.67% of US stocks.
  • The strongest trend for WVE is in Value, which has been heading up over the past 163 days.
  • WVE's current lowest rank is in the Momentum metric (where it is better than 9.38% of US stocks).

WVE Stock Summary

  • Of note is the ratio of Wave Life Sciences Ltd's sales and general administrative expense to its total operating expenses; merely 12.14% of US stocks have a lower such ratio.
  • Revenue growth over the past 12 months for Wave Life Sciences Ltd comes in at 273.05%, a number that bests 97% of the US stocks we're tracking.
  • The volatility of Wave Life Sciences Ltd's share price is greater than that of 86.54% US stocks with at least 200 days of trading history.
  • If you're looking for stocks that are quantitatively similar to Wave Life Sciences Ltd, a group of peers worth examining would be FULC, IDYA, EIGR, ALPN, and DTIL.
  • WVE's SEC filings can be seen here. And to visit Wave Life Sciences Ltd's official web site, go to www.wavelifesciences.com.

WVE Valuation Summary

  • In comparison to the median Healthcare stock, WVE's EV/EBIT ratio is 104.78% lower, now standing at -1.4.
  • WVE's price/sales ratio has moved down 2247.9 over the prior 71 months.
  • Over the past 71 months, WVE's price/sales ratio has gone down 2247.9.

Below are key valuation metrics over time for WVE.

Stock Date P/S P/B P/E EV/EBIT
WVE 2021-08-31 20.5 14.7 -2.2 -1.4
WVE 2021-08-30 19.7 14.1 -2.2 -1.3
WVE 2021-08-27 19.3 13.8 -2.1 -1.3
WVE 2021-08-26 18.6 13.4 -2.0 -1.2
WVE 2021-08-25 19.2 13.8 -2.1 -1.3
WVE 2021-08-24 19.4 13.9 -2.1 -1.3

WVE's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • WVE has a Quality Grade of C, ranking ahead of 33.55% of graded US stocks.
  • WVE's asset turnover comes in at 0.06 -- ranking 311th of 680 Pharmaceutical Products stocks.
  • IONS, CORT, and CPIX are the stocks whose asset turnover ratios are most correlated with WVE.

The table below shows WVE's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-06-30 0.060 1 -4.284
2021-03-31 0.061 1 -4.798
2020-12-31 0.078 1 -7.715
2020-09-30 0.050 1 -5.619
2020-06-30 0.047 1 -5.196
2020-03-31 0.055 1 -4.843

WVE Price Target

For more insight on analysts targets of WVE, see our WVE price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $9.86 Average Broker Recommendation 1.64 (Moderate Buy)

WVE Stock Price Chart Interactive Chart >

Price chart for WVE

WVE Price/Volume Stats

Current price $2.18 52-week high $12.17
Prev. close $2.39 52-week low $2.18
Day low $2.18 Volume 294,700
Day high $2.43 Avg. volume 301,707
50-day MA $3.48 Dividend yield N/A
200-day MA $5.36 Market Cap 128.26M

Wave Life Sciences Ltd. - Ordinary Shares (WVE) Company Bio


WAVE Life Sciences Pte. Ltd., a preclinical biopharmaceutical company, designs, develops, and commercializes nucleic acid therapeutic candidates. The company was founded in 2012 and is based in Simgapore.


WVE Latest News Stream


Event/Time News Detail
Loading, please wait...

WVE Latest Social Stream


Loading social stream, please wait...

View Full WVE Social Stream

Latest WVE News From Around the Web

Below are the latest news stories about Wave Life Sciences Ltd that investors may wish to consider to help them evaluate WVE as an investment opportunity.

Corsicana & Co. Buys Block Inc, Cummins Inc, SPDR Portfolio S&P 500 ETF, Sells iShares ...

Investment company Corsicana & Co. (Current Portfolio) buys Block Inc, Cummins Inc, SPDR Portfolio S&P 500 ETF, Teladoc Health Inc, LTC Properties Inc, sells iShares Core Total USD Bond Market ETF, Texas Capital Bancshares Inc, Deckers Outdoor Corp, Fifth Third Bancorp, Citizens Financial Group Inc during the 3-months ended 2021Q4, according to the most recent filings of the investment company, Corsicana & Co..

Yahoo | January 5, 2022

What You Need To Know About Wave Life Sciences Ltd.'s (NASDAQ:WVE) Investor Composition

If you want to know who really controls Wave Life Sciences Ltd. ( NASDAQ:WVE ), then you'll have to look at the makeup...

Yahoo | January 4, 2022

Vintage Wine Estates marks eight years and one million meals donated through its Angels Share campaign to fight food insecurity

Vintage Wine Estates marks eight years and one million meals donated through its Angels Share campaign to fight food insecurityPR NewswireSANTA ROSA, Calif. 23, 2021 /PRNewswire/ -- Vintage Wine Estates, Inc.

Yahoo | December 24, 2021

Wave Life Sciences (WVE) Receives a Buy from Mizuho Securities

Mizuho Securities analyst Salim Syed maintained a Buy rating on Wave Life Sciences (WVE – Research Report) yesterday and set a price target of $13.00. The company's shares closed last Tuesday at $3.90, close to its 52-week low of $3.78. According to TipRanks.com, Syed has 0 stars on 0-5 stars ranking scale with an average return of -5.7% and a 46.6% success rate. Syed covers the Healthcare sector, focusing on stocks such as Atara Biotherapeutics, Assembly Biosciences, and Coherus Biosciences. The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Wave Life Sciences with a $8.50 average price target.

Brian Anderson on TipRanks | December 1, 2021

Brokerages Expect Wave Life Sciences Ltd. (NASDAQ:WVE) Will Post Earnings of -$0.47 Per Share

Wall Street brokerages expect Wave Life Sciences Ltd. (NASDAQ:WVE) to announce earnings per share of ($0.47) for the current quarter, Zacks Investment Research reports. Five analysts have made estimates for Wave Life Sciences earnings, with the highest EPS estimate coming in at ($0.26) and the lowest estimate coming in at ($0.72). Wave Life Sciences posted []

Transcript Daily | November 20, 2021

Read More 'WVE' Stories Here

WVE Price Returns

1-mo N/A
3-mo -50.34%
6-mo -62.54%
1-year -78.13%
3-year -93.64%
5-year -92.50%
YTD -30.57%
2021 -60.10%
2020 -1.81%
2019 -80.93%
2018 19.77%
2017 34.23%

Continue Researching WVE

Want to see what other sources are saying about Wave Life Sciences Ltd's financials and stock price? Try the links below:

Wave Life Sciences Ltd (WVE) Stock Price | Nasdaq
Wave Life Sciences Ltd (WVE) Stock Quote, History and News - Yahoo Finance
Wave Life Sciences Ltd (WVE) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.881 seconds.